Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS (Unaudited)

v3.24.1.1.u2
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 6,159 $ 6,760
Restricted cash 13
Receivables 134 46
Notes receivable 1,000
Prepaid expenses and other current assets 318 199
Total current assets 6,611 8,018
Property and equipment, net 3 5
Operating lease right-of-use asset, net 32 63
Total assets 6,646 8,086
Current liabilities:    
Accounts payable 371 348
Note payable to related party 500
Other accrued liabilities 155 519
Operating lease liability, current 33 65
Deferred grant revenue 12
Total current liabilities 559 1,444
Total liabilities 559 1,444
Stockholders’ equity (deficit):    
Preferred stock, at amounts paid in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at March 31, 2024 and December 31, 2023. 1 1
Common stock, at amounts paid in, $0.001 par value per share; 225,000,000 shares authorized, 914,234 and 781,503 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively. 1 1
Additional paid-in capital 398,975 398,470
Accumulated deficit (392,890) (391,830)
Total stockholders’ equity 6,087 6,642
Total liabilities and stockholders’ equity $ 6,646 $ 8,086